We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$202M
AUM Growth
+$585K
Cap. Flow
-$6.9M
Cap. Flow %
-3.41%
Top 10 Hldgs %
46.14%
Holding
97
New
4
Increased
11
Reduced
63
Closed
2

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$210K
2
BX icon
Blackstone
BX
+$152K
3
DHR icon
Danaher
DHR
+$126K
4
PFE icon
Pfizer
PFE
+$57.9K
5
FFIV icon
F5
FFIV
+$57.8K

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$904K
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$735K
3
AAPL icon
Apple
AAPL
+$666K
4
GS icon
Goldman Sachs
GS
+$493K
5
ZTS icon
Zoetis
ZTS
+$365K

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Financials 19.59%
3 Industrials 18.05%
4 Healthcare 15.45%
5 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$2.75M 1.36%
8,386
-210
-2% -$66.6K
OKE icon
27
Oneok
OKE
$57.2B
$2.68M 1.32%
36,452
-475
-1% -$33.7K
MLM icon
28
Martin Marietta Materials
MLM
$31.5B
$2.47M 1.22%
3,963
-50
-1% -$31.1K
V icon
29
Visa
V
$684B
$2.39M 1.18%
6,811
-392
-5% -$134K
BAM icon
30
Brookfield Asset Management
BAM
$77.3B
$2.34M 1.15%
44,591
-1,414
-3% -$76K
BAX icon
31
Baxter International
BAX
$13.5B
$2.32M 1.15%
121,415
-11,505
-9% -$230K
CVS icon
32
CVS Health
CVS
$133B
$2.12M 1.04%
26,657
-640
-2% -$50.5K
LMT icon
33
Lockheed Martin
LMT
$134B
$2.1M 1.04%
4,350
-105
-2% -$50.2K
AMZN icon
34
Amazon
AMZN
$2.92T
$2.09M 1.03%
9,063
-195
-2% -$44.6K
JNJ icon
35
Johnson & Johnson
JNJ
$618B
$1.85M 0.91%
8,940
-71
-0.8% -$14K
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$121B
$1.81M 0.9%
3,996
-250
-6% -$108K
META icon
37
Meta Platforms (Facebook)
META
$1.42T
$1.74M 0.86%
2,629
-67
-2% -$44.7K
ACN icon
38
Accenture
ACN
$102B
$1.61M 0.8%
6,005
-246
-4% -$62.5K
QCOM icon
39
Qualcomm
QCOM
$155B
$1.59M 0.79%
9,316
-870
-9% -$149K
ORCL icon
40
Oracle
ORCL
$374B
$1.45M 0.71%
7,421
+30
+0.4% +$7.14K
J icon
41
Jacobs Solutions
J
$15.9B
$1.39M 0.69%
10,504
– –
WFC icon
42
Wells Fargo
WFC
$261B
$1.38M 0.68%
14,838
-1,080
-7% -$93.8K
LYB icon
43
LyondellBasell Industries
LYB
$20B
$1.31M 0.65%
30,240
-6,235
-17% -$282K
CI icon
44
Cigna
CI
$73.7B
$1.3M 0.64%
4,708
-308
-6% -$86.3K
MRK icon
45
Merck
MRK
$322B
$1.05M 0.52%
10,023
-346
-3% -$32.5K
MDT icon
46
Medtronic
MDT
$109B
$1.03M 0.51%
10,750
-238
-2% -$23.1K
FFIV icon
47
F5
FFIV
$22.9B
$901K 0.45%
3,530
+215
+6% +$57.8K
GEHC icon
48
GE HealthCare
GEHC
$30.7B
$782K 0.39%
9,529
-197
-2% -$15.3K
CARR icon
49
Carrier Global
CARR
$51B
$755K 0.37%
14,293
-980
-6% -$54.5K
NVDA icon
50
NVIDIA
NVDA
$4.86T
$737K 0.36%
3,951
-319
-7% -$59.4K
1
2
3 4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Lipe & Dalton's Q4 2025 Portfolio in Review

As of Q4 2025, Lipe & Dalton held 97 positions worth $202M, up 0.29% from $202M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lipe & Dalton withdrew a net $6.9M in Q4 2025, closing 2 positions and reducing 63 holdings. Its most notable exit was Fiserv Inc, an estimated $904K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

Against the trend, Lipe & Dalton opened a new position in Regeneron Pharmaceuticals worth $239K.

  • Lipe & Dalton's largest Q4 2025 buy was Regeneron Pharmaceuticals: 309 shares worth $239K.
  • Lipe & Dalton added most to Danaher in Q4 2025, an estimated $126K increase.
  • Lipe & Dalton's biggest Q4 2025 reduction was Alphabet (Google) Class C, cutting an estimated $735K.
  • Lipe & Dalton fully exited Fiserv Inc in Q4 2025, selling an estimated $904K.
  • Lipe & Dalton's ten largest holdings make up 46% of its $202M portfolio in Q4 2025.
  • Lipe & Dalton opened 4 new positions and closed 2 in Q4 2025.
  • Lipe & Dalton's portfolio value rose 0.29% quarter-over-quarter to $202M.

Based on Lipe & Dalton's 13F filing for Q4 2025, filed 26 Jan 2026.